A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401

被引：0
作者：
In-Jae Oh
Kyu-Sik Kim
Young-Chul Kim
Hee-Jung Ban
Yong-Soo Kwon
Yu-Il Kim
Sung-Chul Lim
Woong-Ki Chung
Taek-Keun Nam
Joo-Young Song
Mee-Sun Yoon
Sung-Ja Ahn
机构：
[1] Chonnam National University Hwasun Hospital,Lung and Esophageal Cancer Clinic
[2] Chonnam National University,Department of Internal Medicine
[3] Chonnam National University,Department of Radiation Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2013年 / 72卷
关键词：
Non-small cell lung cancer; Concurrent chemoradiotherapy; Paclitaxel; Docetaxel; Gemcitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1247 / 1254
页数：7
相关论文
共 50 条
  • [31] Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer
    Cardenal, Felipe
    Arnaiz, Maria Dolores
    Moran, Teresa
    Jove, Josep
    Nadal, Ernest
    Porta, Ruth
    Sole, Josep Maria
    Brao, Isabel
    Palmero, Ramon
    Fuentes, Rafael
    Nunez, Inmaculada
    Caveda, Elena
    Cassinello, Alejo
    LUNG CANCER, 2011, 74 (01) : 69 - 74
  • [32] A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer
    Argiris, A
    Liptay, M
    LaCombe, M
    Marymont, M
    Kies, MS
    Sundaresan, S
    Masters, G
    LUNG CANCER, 2004, 45 (02) : 243 - 253
  • [33] Volumetric PET Parameters Predict Prognosis after Definitive Chemoradiotherapy with Cisplatin/Docetaxel for Stage III Non-Small Cell Lung Cancer
    Katsui, Kuniaki
    Ogata, Takeshi
    Tada, Akihiro
    Sugiyama, Soichi
    Yoshio, Kotaro
    Kuroda, Masahiro
    Kiura, Katsuyuki
    Maeda, Yoshinobu
    Toyooka, Shinichi
    Hiraki, Takao
    Kanazawa, Susumu
    ACTA MEDICA OKAYAMA, 2021, 75 (01) : 15 - 23
  • [34] Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial
    Georgoulias, V
    Samonis, G
    Papadakis, E
    Alexopoulos, A
    Tsiafaki, X
    Rapti, A
    Veslemes, M
    Grigoratou, T
    Palamidas, P
    Kourossis, C
    Mavroudis, D
    Kakolyris, S
    Giannakakis, T
    Vlachonikolis, J
    LUNG CANCER, 2001, 34 : S47 - S51
  • [35] Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Conformal Thoracic Radiation to 74 Gy with Weekly Paclitaxel and Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer
    Bepler, Gerold
    Dilling, Thomas J.
    Wagner, Henry
    Hazelton, Todd
    Williams, Charles
    Chen, Dung-Tsa
    Greenberg, Harvey
    Walsh, Frank
    Simon, George
    Tanvetyanon, Tawee
    Chiappori, Alberto
    Haura, Eric
    Stevens, Craig
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : 553 - 558
  • [36] Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: A preliminary report
    Shepherd, FA
    Burkes, R
    Cormier, Y
    Crump, M
    Feld, R
    Strack, T
    LUNG CANCER, 1996, 14 (01) : 135 - 144
  • [37] Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer
    Kaya, Ali Osman
    Buyukberber, Suleyman
    Benekli, Mustafa
    Coskun, Ugur
    Sevinc, Alper
    Akmansu, Muge
    Yildiz, Ramazan
    Ozturk, Banu
    Yaman, Emel
    Kalender, Mehmet Emin
    Orhan, Okan
    Yamac, Deniz
    Uner, Aytug
    MEDICAL ONCOLOGY, 2010, 27 (01) : 152 - 157
  • [38] Influence of altering administration sequence of docetaxel, gemcitabine and cisplatin in patients with advanced non-small cell lung cancer
    Harita, S
    Watanabe, Y
    Kiura, K
    Tabata, M
    Takigawa, N
    Kuyama, S
    Kozuki, T
    Kamei, H
    Tada, A
    Okimoto, N
    Genba, K
    Tada, S
    Ueoka, H
    Hiraki, S
    Tanimoto, M
    ANTICANCER RESEARCH, 2006, 26 (2B) : 1637 - 1641
  • [39] A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer
    Pallis, AG
    Agelidou, A
    Papakotoulas, P
    Tsaroucha, A
    Agelidou, M
    Agelaki, S
    Androulakis, N
    Vamvakas, L
    Gerogianni, A
    Kotsakis, A
    Kentepozidis, N
    Georgoulias, V
    LUNG CANCER, 2006, 52 (02) : 165 - 171
  • [40] Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer
    Park, Se Hoon
    Hong, Junshik
    Kim, Young Saing
    Kim, Yujin
    Kyung, Sun Young
    An, Chang Hyeok
    Lee, Sang Pyo
    Park, Jeong Woong
    Jeong, Sung Hwan
    Park, Jinny
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae Hoon
    LUNG CANCER, 2008, 62 (01) : 72 - 77
12345